DoctorAlastair Fortune

(He/Him)

Postdoctoral Research Fellow - Neuroscience

Menzies Institute for Medical Research

FUNDED PROJECTS

  • GRANT
    Harnessing genomics to find treatments for anorexia nervosa
    1 Jan 2027 - 30 Jun 2028
    People funded by this grant:
    • Reay W,
    • Blizzard C,
    • Foldi C,
    • Fortune A
    Project Total: $95,000; Anorexia nervosa is a serious mental health condition that causes people to restrict the amount of food they eat, with symptoms of distressing anxiety about their weight and appearance. Unfortunately, anorexia nervosa has one of the highest mortality rates of any mental health condition, due to complications of malnutrition, and costs Australia billions of dollars a year. Despite this immense impact, there are still no approved drugs that can help people living with anorexia. This project seeks to use information from our genes to pinpoint which drugs may be useful as treatments for anorexia. We will then take promising drugs and investigate how they impact nerve cells grown in a dish. By combining these different approaches, we will be able shortlist drugs that may be promising new treatments which can then be candidates for clinical trial. Funded by: Donation via Menzies Institute for Medical Research - Donation ($95,000); University of Tasmania.
  • GRANT
    Vascular Vulnerabilities and MS Pathology
    Multiple Sclerosis Australia1 Jan 2026 - 31 Dec 2028
    People funded by this grant:
    • Young K,
    • Sutherland B,
    • Moloney R,
    • Fortune A
    Project Total: $397,239; The brain has extremely high oxygen and energy demands. This makes blood supply critical for neuron health. As people with Multiple Sclerosis (MS) have a reduced brain blood flow, this could directly promote neurodegeneration and disability progression. However, it is unclear whether genetic factors, signals within the lesion environment, or a combination of both, lead to brain hypoperfusion in people with MS. To examine this, we will use induced pluripotent stem cells (iPSCs), generated from the blood of people with and without MS, to generate the vascular cell types that regulate brain blood flow. iPSCs and the resulting vascular cell types will have the same DNA sequence as the person they were made from. We will expose these cells to control conditions, as well as the signals they would experience inside an MS lesion to determine how the properties that regulate capillary barrier integrity and blood flow are impacted. We will also determine how changing blood flow can impact the level of myelin loss and neuronal injury in an inflammatory model of demyelination. Our project has the potential to identify ways to target blood vessels to improve integrity and blood flow regulation within the brain of a people with MS. We predict that even after MS develops, targeting and improving blood vessel health could be critical for supporting brain remyelination and preventing neuron cell death. As neuron cell death causes disability to increase, our goal is to save neurons and reduce disease progression. Funded by: Multiple Sclerosis Australia - Project ($397,626); University of Tasmania.
  • GRANT
    Are pericytes dysfunctional in MS?
    1 Aug 2025 - 31 Jul 2026
    People funded by this grant:
    • Fortune A,
    • Young K
    Project Total: $24,964; The exact cause and mechanisms underlying the development of multiple sclerosis (MS) are poorly understood but we know that the development of MS is driven by a complex interplay between genes and environmental factors. The genetic risk factors of MS strongly implicate immune and vascular cells in driving MS initiation. Despite this, few studies have explored the role that vascular cells play in disease development. We aim to find out how MS genes could alter brain vascular cells, even before immune cell activation can damage them. We will use induced pluripotent stem cells from people with MS. Stem cells are immature cells that can produce any cell type in the body, and have the DNA (genes) of the unaffected or MS donor. We will use iPSCs from people with and without MS, to make pericytes and compare their function. Pericytes are cells that sit on brain blood vessels and contract or relax to regulate blood flow. Blood flow is altered in people with MS and we will determine whether this is due to DNA programmed differences in MS pericytes. We will also find out how pericytes respond to an MS lesion-like environment. This project will determine if and how pericytes promote blood vessel pathology in people with MS Funded by: Multiple Sclerosis Australia - Grant-Incubator ($24,964); University of Tasmania.
  • GRANT
    Redirecting glial signalling to prevent MS progression
    1 Jan 2024 - 31 Dec 2026
    People funded by this grant:
    • Fletcher J
    Project Total: $225,000; The MS community rates the development of a cure for MS via repair and regeneration of brain cells? as their highest priority1. My research vision will see this become a reality. Over the course of this fellowship, I will lead my team and, using 4 distinct approaches, address 2 outstanding research questions: 1) What impedes remyelination in MS? and 2) How can we overcome this to promote brain repair? Funded by: Multiple Sclerosis Australia - Fellowship-Postdoctoral ($225,000); University of Tasmania.
  • GRANT
    WHAT CAUSES MULTIPLE SCLEROSIS ONSET AND PROGRESSION?
    1 Jan 2024 - 31 Dec 2028
    People funded by this grant:
    • Young K,
    • Fletcher J,
    • Blackburn N
    Project Total: $3,653,279; In multiple sclerosis (MS) immune cells attack the brain. A person's genes, environment and lifestyle choices can influence whether they develop MS and the severity of disease. But we don't know how these factors alter brain cell function to start or worsen MS. To figure this out, we studied families with multiple members who have MS. We identified gene mutations carried by people with MS, with the potential to change brain cells function. We will now determine how brain cells are affected. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Ideas ($7,306,558); University of Tasmania ($480,068).
  • GRANT
    Multiple Sclerosis - Pathways to Protecting and Repairing the Central Nervous System
    1 Jan 2022 - 31 Dec 2026
    People funded by this grant:
    • Young K
    Project Total: $650,000; This application describes laboratory research that aims to identify signalling pathways that precipitate MS, learn how neural circuit function is impacted by MS pathology, and design and translate treatments to protect and repair the CNS. Funded by: Multiple Sclerosis Australia - Fellowship-Senior ($650,000); University of Tasmania ($425,040).